IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cytomx Therapeutics Inc COM

CUSIP: 32384F105 | 1 institutional holders

Quarters

Q2 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

CT Mason1,888
0.0% of portfolio›$43
StyleTurnoverLocationFiled
CT Mason
1,888$430.0%N/AN/ABoston, MA2018-08-15